UPDATE 1-Johnson & Johnson to buy private drug developer for $1.75 bln
September 30, 2014 at 10:40 AM EDT
Sept 30 (Reuters) - Johnson & Johnson agreed to pay $1.75 billion in cash to buy privately held Alios BioPharma Inc, which is developing a drug for a respiratory viral infection for which there is no approved treatment.
